Kardigan, Inc. (NASDAQ: KARD) is a Healthcare company (Biotechnology) with a market capitalization of $1.2B. The Maz Rating grades it against the other companies in its sector.
Kardigan, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $13.19, Kardigan, Inc. trades at 2.1x book value. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of -78.0%, return on invested capital of -36.3% and a free cash flow yield of -14.4%. On the balance sheet: a debt-to-equity ratio of 0.02 and a current ratio of 10.62. Over the past 52 weeks the share price ranged from $12.23 to $27.00, with a beta of 6.05.
Kardigan, Inc. does not currently pay a dividend.
1 Wall Street analyst rating covers the stock: 1 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.